Evidence map›Paper›PMID 39381720›Full record

ArticleCOVID2023

Extraction Free RT-PCR Surveillance Testing and Reporting for SARS-CoV-2.

Patrick Carney, Tyler Duellman, Jia-Yi Chan, Lauren Wells, Michael Tessmer, Leah Frater-Rubsam, Molly Zeller, Mark Field, James Speers, Kelly Tyrrell and 11 more

Abstract read
In one paragraph

Article in COVID, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Patrick CarneyMolecular and Environmental Toxicology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Tyler DuellmanBiotechnology Center, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Jia-Yi ChanBiotechnology Center, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Lauren WellsBiotechnology Center, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Michael TessmerDivision of Information Technology, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Leah Frater-RubsamBiotechnology Center, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Molly ZellerBiotechnology Center, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Mark FieldDivision of Information Technology, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
James SpeersBiotechnology Center, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Kelly TyrrellUniversity Communications, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Luke ThompsonUniversity Health Services, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Michael BondurantDivision of Information Technology, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Tami MorinUniversity Health Services, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Tamra DagnonUniversity Health Services, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Brian GoffUniversity Health Services, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Carissa RundeDivision of Information Technology, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Sandra Splinter-BondurantBiotechnology Center, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Charles KonsitzkeBiotechnology Center, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Patrick KellyUniversity Health Services, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Christopher BradfieldMolecular and Environmental Toxicology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Joshua HymanBiotechnology Center, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
Training in Cancer Biology Training GrantT32CA009135 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI SUGDEN, WILLIAM M. · 1985 to 2024
$10.4M
The PAS Sensor Family and Human HealthR35ES028377 · NIEHS · UNIVERSITY OF WISCONSIN-MADISON · PI BRADFIELD, CHRISTOPHER A · 2017 to 2024
$6.7M
Integrated Training For Physician-ScientistsT32GM140935 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Anna Huttenlocher, Jeniel E Nett · 2021 to 2026
$6.5M
NCI NIH HHS P30 CA014520NCI NIH HHS T32 CA009135NIEHS NIH HHS R35 ES028377NIGMS NIH HHS T32 GM140935
6 · The paper itself

Abstract

The COVID-19 pandemic necessitated sensitive, fast and inexpensive testing for the virus on university campuses across the nation in 2020 prior to the widespread availability of vaccines. Early testing efforts were limited by bottlenecks on reagents, low throughput testing options and slow return of test results. In this paper we detail the testing pipeline we established at the University of Wisconsin-Madison for rapid, inexpensive and sensitive surveillance testing for SARS-CoV-2 and highlight the strengths of the platform that would allow it to be applied to other disease surveillance projects, SARS-CoV-2 variant testing or future pandemics.

Indexed as

COVID-19RT-PCRSARS-CoV-2Surveillance

Identifiers

PMID39381720
PMCPMC11460792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.